Andre Johnson

Andre Johnson currently serves as the Director of Clinical Phase QC at Seqirus, a position held since October 2021. Prior to this role, Andre held various senior positions in quality control, including Senior Director at NOVAVAX INC and AstraZeneca, as well as Director of Quality Control at Paragon Bioservices, Inc. The career trajectory includes significant contributions to analytical lifecycle management at Shire and leadership in GMP testing at Wyeth Vaccine/Pfizer. Educational qualifications include a Bachelor of Science in Physics from Guilford College, attained between 1988 and 1992.